PRECLINICAL STUDY
Beat-to-Beat Variability of Repolarization Determines Proarrhythmic Outcome in Dogs Susceptible to Drug-Induced Torsades de Pointes
Morten B. Thomsen, PhD*, ,2,*,
Paul G.A. Volders, MD, PhD,1,
Jet D.M. Beekman*,
Jørgen Matz, PhD ,3 and
Marc A. Vos, PhD*
* Department of Medical Physiology, Heart Lung Center Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands
Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands
Center of Excellence, Cardiovascular Research, H. Lundbeck, Copenhagen, Denmark.
Manuscript received March 29, 2006;
revised manuscript received May 4, 2006,
accepted May 9, 2006.
* Reprint requests and correspondence: Dr. Marc A. Vos, Department of Medical Physiology, Yalelaan 50, NL 3584 CM Utrecht, the Netherlands. (Email: m.a.vos{at}umcutrecht.nl).
OBJECTIVES: We investigated whether increasing or decreasing beat-to-beat variability of repolarization (BVR) would change drug-induced proarrhythmic outcome accordingly.
BACKGROUND: Increased variability of repolarization has been suggested as a prelude to proarrhythmic circumstances in experimental and clinical situations.
METHODS: The non-cardiovascular, IKr-blocking drug sertindole was administered to anesthetized dogs with chronic atrioventricular block. Three interventions were used to prevent or suppress sertindole-induced torsades de pointes (TdP).
RESULTS: Supratherapeutic doses of sertindole (1.0 mg/kg intravenously) induced TdP in 10 of 13 dogs whereas 0.2 mg/kg induced no TdP, despite increases in QT intervals by both doses. The BVR, quantified as short-term variability (STV) from Poincaré plots, was the only parameter that predicted TdP outcome (1.0 mg/kg sertindole: 2.3 ± 0.7 ms to 5.1 ± 2.1 ms, p < 0.05; 0.2 mg/kg sertindole: 2.3 ± 0.8 ms to 3.2 ± 1.1 ms, p = NS). Interventions: 1) KCl, intravenous, reduced the incidence of sertindole-induced TdP from 6 of 7 to 1 of 7 dogs (p < 0.05) and prevented sertindole-related increase of STV: 3.0 ± 1.1 ms vs. 4.5 ± 1.3 ms (p < 0.05); 2) levcromakalim (IK,ATP activator) reduced sertindole-induced TdP and decreased STV from 4.9 ± 2.1 ms to 2.6 ± 0.9 ms (p < 0.05); 3) steady-state ventricular pacing (60 beats/min) abolished sertindole-induced TdP and decreased STV from 4.9 ± 1.5 to 3.2 ± 1.0 (p < 0.05). Torsades de pointes reappeared upon return to non-paced idioventricular rhythm. None of the 3 interventions reduced the sertindole-induced prolonged QT interval.
CONCLUSIONS: Proarrhythmic intervention is related to an increase in BVR, whereas antiarrhythmic treatment is associated with a decrease in BVR. The BVR is superior to QT interval prolongation in the prediction and prevention of drug-induced TdP in this experimental model.
|
Abbreviations and Acronyms
| | BVR = beat-to-beat variability of repolarization | | CAVB = chronic atrioventricular block | | CL = cycle length | | IVR = idioventricular rhythm | | LV = left ventricle/ventricular | | MAPD = monophasic action potential duration | | QTc = heart rate–corrected QT intervals | | RV = right ventricle/ventricular | | STV = short-term variability | | TdP = torsades de pointes |  MAPD = interventricular dispersion of repolarization duration |
|
This article has been cited by other articles:
|
|
|
|
 
J. Seegers, M. A. Vos, P. Flevari, R. Willems, C. Sohns, D. Vollmann, L. Luthje, D. T. Kremastinos, V. Flore, M. Meine, et al.
Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype
Europace,
November 23, 2011;
(2011)
eur352v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Dunnink, J. M. van Opstal, P. Oosterhoff, S. K. G. Winckels, J. D. M. Beekman, R. van der Nagel, S. Cora Verduyn, and M. A. Vos
Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog
Europace,
September 22, 2011;
(2011)
eur311v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Baumert, M. P. Schlaich, E. Nalivaiko, E. Lambert, C. I. Sari, D. M. Kaye, M. D. Elser, P. Sanders, and G. Lambert
Relation between QT interval variability and cardiac sympathetic activity in hypertension
Am J Physiol Heart Circ Physiol,
April 1, 2011;
300(4):
H1412 - H1417.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Corrias, X. Jie, L. Romero, M. J. Bishop, M. Bernabeu, E. Pueyo, and B. Rodriguez
Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations
Phil Trans R Soc A,
June 28, 2010;
368(1921):
3001 - 3025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Antoons, A. Oros, J. D.M. Beekman, M. A. Engelen, M. J.C. Houtman, L. Belardinelli, M. Stengl, and M. A. Vos
Late Na+ Current Inhibition by Ranolazine Reduces Torsades de Pointes in the Chronic Atrioventricular Block Dog Model
J. Am. Coll. Cardiol.,
February 23, 2010;
55(8):
801 - 809.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hinterseer, M. B. Thomsen, B.-M. Beckmann, A. Pfeufer, R. Schimpf, H.-E. Wichmann, G. Steinbeck, M. A. Vos, and S. Kaab
Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study
Eur. Heart J.,
January 2, 2008;
29(2):
185 - 190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Thireau, B. L. Zhang, D. Poisson, and D. Babuty
Heart rate variability in mice: a theoretical and practical guide
Exp Physiol,
January 1, 2008;
93(1):
83 - 94.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K.G. Winckels, M. B. Thomsen, P. Oosterhoff, A. Oros, J. D.M. Beekman, N. J.M. Attevelt, L. Kretzers, and M. A. Vos
High-Septal Pacing Reduces Ventricular Electrical Remodeling and Proarrhythmia in Chronic Atrioventricular Block Dogs
J. Am. Coll. Cardiol.,
August 28, 2007;
50(9):
906 - 913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
